Reply to thread

We've speculated about this. The equine study suggests that the pharmacokinetics of testosterone suspension are complicated and prolonged, which makes it less of a candidate for keeping the HPTA active. Ester-less testosterone in oil (TNE) is perhaps a little more promising, but nobody has turned up any studies, so we still don't know if the half-life is short enough.